1. Kushner GM, Alpert B. Osteomyelitis, osteoradionecrosis and BRONJ. In : Miloro M, Ghali GE, Larsen PE, Waite PD, editors. Peterson's principles of oral and maxillofacial surgery. 3rd ed. Shelton: People's medical publishing house;2012. p. 861–874.
2. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. J Oral Maxillofac Surg. 2009; 67(5 Suppl):2–12. PMID:
19371809.
Article
3. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007; 65:369–376. PMID:
17307580.
4. Marx RE. Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws: history, etiology, prevention, and treatment. 2nd ed. Chicago: Quintessence Publishing;2011.
5. Rasmusson L, Abtahi J. Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment. Int J Dent. 2014; 2014:471035. PMID:
25254048.
Article
6. Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg. 2015; 44:568–585. PMID:
25726090.
Article
7. Tallarico M, Canullo L, Xhanari E, Meloni SM. Dental implants treatment outcomes in patient under active therapy with alendronate: 3-year follow-up results of a multicenter prospective observational study. Clin Oral Implants Res. 2015; DOI:
10.1111/clr.12662. [Epub ahead of print].
Article
8. Rugani P, Kirnbauer B, Acham S, Truschnegg A, Jakse N. Implant placement adjacent to successfully treated bisphosphonate-related osteonecrosis of the jaw (BRONJ). J Oral Implantol. 2015; 41:377–381. PMID:
24593250.
Article
9. Kwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin HI. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin Oral Implants Res. 2014; 25:632–640. PMID:
23278625.
Article
10. Memon S, Weltman RL, Katancik JA. Oral bisphosphonates: early endosseous dental implant success and crestal bone changes. A retrospective study. Int J Oral Maxillofac Implants. 2012; 27:1216–1222. PMID:
23057037.
11. Dixon RB, Tricker ND, Garetto LP. Bone turnover in elderly canine mandible and tibia. J Dent Res. 1997; 76:336.
12. Madrid C, Sanz M. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res. 2009; 20(Suppl 4):87–89. PMID:
19663954.
Article
13. Ata-Ali J, Ata-Ali F, Peñarrocha-Oltra D, Galindo-Moreno P. What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis. Clin Oral Implants Res. 2016; 27:e38–e46. PMID:
25406770.
Article